SCYNEXIS INC. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by SCYNEXIS, Inc. on April 21, 2020, regarding a notice received from the Nasdaq Stock Market. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol SCYX.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the closing bid price of the company's common stock, which fell below the $1.00 minimum requirement for continued listing.
Material Changes and Listing Status
On April 21, 2020, SCYNEXIS received notification from Nasdaq that its common stock closing bid price had been below $1.00 per share for 30 consecutive business days. The highest closing bid price during this period was $0.995. Nasdaq does not round prices for this determination. This notice does not immediately affect the listing status but initiates a compliance period.
Outlook, Risks, and Contingencies
- Compliance Period: SCYNEXIS has 180 calendar days from July 1, 2020, until December 28, 2020, to regain compliance.
- Compliance Criteria: The company must maintain a closing bid price of at least $1.00 for a minimum of 10 consecutive business days before the deadline.
- Contingency Plans: If compliance is not met by December 28, 2020, the company may transfer to the Nasdaq Capital Market, potentially qualifying for an additional 180-day period if it meets other listing requirements (excluding bid price) and effects a reverse stock split if necessary.
- Delisting Risk: Failure to qualify for an additional period or cure the deficiency may result in delisting. The company retains the right to appeal a delisting determination to a Nasdaq Hearings Panel.
Key Facts for Investor Verification
- Verify the current closing bid price of SCYX to determine if the 10-day compliance threshold has been met.
- Monitor announcements regarding a potential reverse stock split to address the bid price deficiency.
- Check for any updates on the company's intention to transfer to the Nasdaq Capital Market if the current compliance period expires without resolution.
- Review subsequent filings for any appeal notices to the Nasdaq Hearings Panel if delisting is threatened.